Among secondary end points , levels of - glutamyl transpeptidase decreased @ % -@ % , on average , among subjects given OCA , vs a @ % decrease in the group given placebo ; levels of alanine aminotransferase decreased @ % -@ % on average among subjects given OCA vs none of the patients given placebo .